DK0559706T3 - 2 beta,19-methylenamino-broforbundne steroider som aromataseinhibitorer. - Google Patents

2 beta,19-methylenamino-broforbundne steroider som aromataseinhibitorer.

Info

Publication number
DK0559706T3
DK0559706T3 DK91920606.0T DK91920606T DK0559706T3 DK 0559706 T3 DK0559706 T3 DK 0559706T3 DK 91920606 T DK91920606 T DK 91920606T DK 0559706 T3 DK0559706 T3 DK 0559706T3
Authority
DK
Denmark
Prior art keywords
beta
methyleneamino
aromatase inhibitors
bridged steroids
steroids
Prior art date
Application number
DK91920606.0T
Other languages
English (en)
Inventor
Norton P Peet
J Oneal Johnston
Joseph P Burkhart
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0559706T3 publication Critical patent/DK0559706T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0042Nitrogen only
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91920606.0T 1990-11-30 1991-10-17 2 beta,19-methylenamino-broforbundne steroider som aromataseinhibitorer. DK0559706T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/621,183 US5126488A (en) 1990-11-30 1990-11-30 2β,19-methyleneamino bridged steroids as aromatase inhibitors

Publications (1)

Publication Number Publication Date
DK0559706T3 true DK0559706T3 (da) 1997-09-08

Family

ID=24489088

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91920606.0T DK0559706T3 (da) 1990-11-30 1991-10-17 2 beta,19-methylenamino-broforbundne steroider som aromataseinhibitorer.

Country Status (15)

Country Link
US (1) US5126488A (da)
EP (1) EP0559706B1 (da)
JP (1) JP3021651B2 (da)
KR (1) KR100200462B1 (da)
AT (1) ATE154606T1 (da)
AU (1) AU647226B2 (da)
CA (1) CA2096020C (da)
DE (1) DE69126622T2 (da)
DK (1) DK0559706T3 (da)
ES (1) ES2104736T3 (da)
FI (1) FI932446A0 (da)
GR (1) GR3024298T3 (da)
HU (1) HU213608B (da)
NO (1) NO302123B1 (da)
WO (1) WO1992009619A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510340A (en) * 1992-06-12 1996-04-23 Sri International Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use
DE69942578D1 (de) 1998-05-22 2010-08-26 Univ R Bifunktionelle moleküle sowie darauf basierende therapien.
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322416A (en) * 1980-06-27 1982-03-30 Merrell Dow Pharmaceuticals Inc. 10-Alkynyl steroids
CA2032311C (en) * 1989-12-20 2002-08-27 Norton P. Peet 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase inhibitors

Also Published As

Publication number Publication date
ATE154606T1 (de) 1997-07-15
JP3021651B2 (ja) 2000-03-15
CA2096020C (en) 2003-06-17
US5126488A (en) 1992-06-30
EP0559706B1 (en) 1997-06-18
AU9027991A (en) 1992-06-25
HUT64365A (en) 1993-12-28
JPH06509543A (ja) 1994-10-27
ES2104736T3 (es) 1997-10-16
FI932446A (fi) 1993-05-28
DE69126622D1 (de) 1997-07-24
FI932446A0 (fi) 1993-05-28
NO931951L (no) 1993-05-28
AU647226B2 (en) 1994-03-17
DE69126622T2 (de) 1997-10-23
HU213608B (en) 1997-08-28
KR100200462B1 (ko) 1999-06-15
NO302123B1 (no) 1998-01-26
WO1992009619A1 (en) 1992-06-11
NO931951D0 (no) 1993-05-28
GR3024298T3 (en) 1997-10-31
EP0559706A4 (da) 1994-02-09
CA2096020A1 (en) 1992-05-31
EP0559706A1 (en) 1993-09-15

Similar Documents

Publication Publication Date Title
SE8603046D0 (sv) Substituted androsta-1,4-diene-3,17-diones and process for their preparation
NO842408L (no) Fremgangsmaate ved fremstilling av 1-alkyl-androsta-1,4-dien-3,17-dioner
DK0559706T3 (da) 2 beta,19-methylenamino-broforbundne steroider som aromataseinhibitorer.
DE68911157D1 (de) Synthese von 6-Methylenandrosta-1,4-dien-3,17-dion-Derivate.
HU9202100D0 (en) New 16-methyl-pregna-1,4-diene-3,20-dione derivatives
NO914710L (no) Fremgangsmaate for fremstilling av 2beta,19-ethylenbroede steroider som aromataseinhibitorer
PT1196428E (pt) Esteroides substituidos com 11 beta-aril-17, 17-espirotiolano